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Table. Factors predictive of unplanned readmission after lower extremity
bypass (LEBP)
Predictive factors OR 95% CI P
Predischarge
Urinary tract infection 5.39 1.32-21.97 .019
Surgical site infection 3.73 1.09-12.81 .037
Graft failure 2.51 1.07-5.89 .035
Wound debridement 2.10 1.35-3.27 .001
Transfusion 1.36 1.14-1.62 .001
Dialysis dependence 1.65 1.25-2.17 0
Emergency index surgery 1.41 1.02-1.95 .04
Preoperative foot infection 1.28 1.08-1.51 .004
Body mass index >30 kg/m2 1.25 1.06-1.47 .009
Distal bypass (infrapopliteal target) 1.25 1.06-1.46 .006
Diabetes 1.25 1.06-1.46 .007
Elective index surgery 1.24 1.04-1.48 .015
Bleeding disorder/anticoagulation 1.21 1.02-1.43 .031
Postoperative length of stay 0.98 0.96-0.99 .008
CI, Conﬁdence interval; OR, odds ratio.
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828 Abstracts September 2014methods (bypass 2.9 6 0.9 cm vs stent graft 3.1 6 1.0 cm, P ¼ .5). Pri-
mary patency at 1 and 3 years was 82% and 82% for bypass and 66% and
44% for stent graft, respectively (P ¼ .08). Predictors of loss of primary
patency were stent graft (odds ratio [OR], 6.5; P < .05) and fewer patent
outﬂow vessels (OR, 3.0; P < .05). Secondary patency at 1 and 3 years was
95% and 89% after bypass vs 100% after stent grafting (P ¼ .2; Fig). Hy-
pertension was protective (OR, 0.4; P < .05). No patient required ampu-
tation. Survival at 3 years was similar at 82% after bypass and 89% after
stent grafting (P ¼ .94). Mean length of stay was longer after bypass
(3.6 6 3.8 vs 1.1 6 0.5 days, P < .01).
Conclusions: Although primary patency seems to be worse after stent
graft exclusion of popliteal aneurysms, reinterventions are commonly suc-
cessful and result in an excellent secondary patency rate. Older patients
with limited survival may beneﬁt from stent grafting, whereas patients
with limited outﬂow may beneﬁt from bypass.
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Objective(s): Endovascular revascularization is an established
approach for limb salvage in the setting of critical limb ischemia. However,
failure rate of anterograde recanalization in complex femoropopliteal to
infrapopliteal occlusions is as high as 20%. We report a series of 19 patients
who underwent transpedal access retrograde recanalization of below-the-
knee chronic total occlusions after a failed anterograde attempt.
Methods: Between 2011 and 2014, 19 patients (15 men, 4 women),
aged 68 6 12 years, underwent percutaneous pedal access for retrograde
endovascular treatment of advanced tibial vessel disease. All patients had un-
dergone prior unsuccessful attempts of antegrade revascularization. Pedal
vessel access was followed by angioplasty or stenting, or both, and comple-
tion angiogram. Patients were followed up with duplex ultrasound imaging
to evaluate for patency.
Results: Retrograde pedal access was successful in all patients (dorsalis
pedis, n ¼ 11; posterior tibial, n ¼ 5; anterior tibial, n ¼ 3). Retrograde
revascularization was achieved in 12 patients (63%) using balloon angio-
plasty (n ¼ 12) and balloon angioplasty with stent placement (n ¼ 1).
Revascularization failed in seven patients (37%). Vessels revascularized
included the posterior tibial (n ¼ 3), anterior tibial (n ¼ 3), dorsalis pedis
(n ¼ 8), and the popliteal artery (n ¼ 3). Duplex ultrasound imaging at 2
and 6 months postoperative showed vessel patency. There were no in hos-
pital adverse events.
Conclusions: Pedal vessel access for retrograde angioplasty with or
without stent placement is a feasible option and enhances endovascular op-
tions for revascularization in complex below-the-knee vessel disease with
good results.
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Objectives: Readmission after lower extremity bypass (LEBP) is com-
mon, yet the indication for readmission and its relationship to reoperation
has not been well described. We used the newly available National Surgical
Quality Improvement Project (NSQIP) parameters to evaluate unplanned
readmission #30 days of LEBP.
Methods: All patients undergoing LEBP in the 2012 NSQIP were
identiﬁed. Indications for 30-day reoperation and readmission were identi-
ﬁed. Independent predictors of readmission were determined using logistic
regression. Unplanned readmission was deﬁned as a readmission not
planned at time of index procedure.
Results: We identiﬁed 5375 cases. A total of 858 (16%) underwent
readmission, and 821 (15%) were unplanned readmissions. Incisional surgi-
cal site infection (SSI) was the most common indication for readmission
(36%), followed by wound disruption (13%), and non-SSI wound-related>Eastern Vascular Society
yNew England Society for Vascular Surgerycomplications (14%), including cellulitis (5%), gangrene/tissue loss (5%),
hematoma (3%), and seroma (2%). On multivariable analysis (Table), predis-
charge urinary tract infection was the most signiﬁcant predictor of un-
planned readmission (odds ratio [OR], 5.4) followed by predischarge SSI
(OR, 3.7), graft failure (OR, 2.5), and wound debridement (OR, 2.1).
Amputation before discharge was not predictive of readmission (OR, 1.1;
95% conﬁdence interval, 0.7-1.6). Among patients who were readmitted,
106 (13%) underwent amputation, with 55 (7%) minor (toe or partial
foot), and 51 (6%) major (above-knee or below-knee). A total of 536 pa-
tients underwent predischarge reoperations (65%), most commonly for graft
revision (31%), wound debridement (21%), and amputation (minor, 21%;
major, 12%). A total of 413 patients underwent postdischarge reoperations
(50%), most commonly for wound debridement (38%), graft revision (23%),
and amputation (minor, 13%; major, 12%; Table).
Conclusions: This is the ﬁrst review of data on LEBP patients from a
national database that includes information on the indication for readmis-
sion and speciﬁc reoperation. Although wound debridement is predictive
of unplanned readmission, amputation is not. The prior iterations of NSQIP
have underestimated the number of wound-related complications leading to
readmission. These data may suggest a role for increased outpatient wound
surveillance and early outpatient intervention for wound-related complica-
tions, when possible, to prevent the need for unplanned readmission.
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Objectives: Treatment of chronic venous ulcers (CVU) is difﬁcult and
resource-intensive, with reported healing rates of 20% to 50% with local
wound care and compression. Human viable wound matrix (HVWM) con-
tains extracellular matrix, growth factors, and several viable cells, including
mesenchymal stem cells. In this study, we compared healing characteristics
of CVU treated with HVWM vs standard of care.
Methods: This prospective single-center trial included patients with
duplex ultrasound conﬁrmed CVU of at least 12-weeks’ duration that had
failed standard care for at least 6 weeks. Patients with active infections
and ischemia (ankle-brachial index <0.8) were excluded. All patients
received standard multilayer compression bandages and local wound care.
Half the patients also received HVWM applications once every 1 to 2 weeks
for 6 weeks. The primary outcome was the proportion of completely healed
wounds (ulcer healing rate). The secondary outcome was the percentage
change in total ulcer surface area during 6 weeks of follow-up.
Results: All 20 patients enrolled were men; mean age was 68 years.
Duplex ultrasound imaging conﬁrmed superﬁcial, or a mixture of superﬁcial>Eastern Vascular Society
